We are live on ! Find out more
WCMNY

Westchester Capital Management (New York) Portfolio holdings

AUM $2.21B
1-Year Est. Return 26.02%
This Fund
S&P 500
This Quarter Est. Return
+8.62%
1 Year Est. Return
+26.02%
3 Year Est. Return
+99.86%
5 Year Est. Return
+236.34%
10 Year Est. Return
+1,523.35%
AUM
$3.64B
AUM Growth
+$85.7M
Cap. Flow
-$35.8M
Cap. Flow %
-0.98%
Top 10 Hldgs %
32.26%
Holding
629
New
150
Increased
117
Reduced
17
Closed
182

Sector Composition

Rank Sector Weight
1 Financials 41.42%
2 Technology 12.77%
3 Healthcare 11.09%
4 Industrials 10.67%
5 Energy 4.51%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
SDAC
126
DELISTED
Sustainable Development Acquisition I Corp. Class A Common Stock
SDAC
$6.75M 0.19%
671,144
+500,000
+292% +$4.99M
ANAC
127
DELISTED
Arctos NorthStar Acquisition Corp.
ANAC
$6.68M 0.18%
+662,506
New +$6.63M
COCH icon
128
Envoy Medical
COCH
$57.5M
$6.63M 0.18%
656,307
+200,000
+44% +$1.99M
KNBE
129
DELISTED
KnowBe4, Inc. Class A Common Stock
KNBE
$6.56M 0.18%
+264,759
New +$6.45M
THCP
130
DELISTED
Thunder Bridge Capital Partners IV, Inc. Class A Common Stock
THCP
$6.44M 0.18%
+641,371
New +$6.3M
BGSX
131
DELISTED
Build Acquisition Corp.
BGSX
$6.31M 0.17%
+630,193
New +$6.26M
FTAA
132
DELISTED
FTAC Athena Acquisition Corp. Class A Ordinary Share
FTAA
$6.28M 0.17%
621,110
CERO
133
DELISTED
CERo Therapeutics
CERO
$6.27M 0.17%
306
+75
+32% +$1.53M
CFIV
134
DELISTED
CF Acquisition Corp. IV Class A common stock
CFIV
$5.97M 0.16%
595,058
FCAX
135
DELISTED
Fortress Capital Acquisition Corp.
FCAX
$5.97M 0.16%
590,881
+36,377
+7% +$365K
AONC
136
DELISTED
American Oncology Network, Inc. Class A Common Stock
AONC
$5.96M 0.16%
593,690
+112,782
+23% +$1.12M
WPCB
137
DELISTED
Warburg Pincus Capital Corporation I-B
WPCB
$5.94M 0.16%
589,109
+114,106
+24% +$1.14M
LCAA
138
DELISTED
L Catterton Asia Acquisition Corp Class A Ordinary Shares
LCAA
$5.93M 0.16%
587,501
UTAA
139
DELISTED
UTA Acquisition Corporation Class A Ordinary Shares
UTAA
$5.86M 0.16%
+574,185
New +$5.81M
LOKM
140
DELISTED
Live Oak Mobility Acquisition Corp.
LOKM
$5.84M 0.16%
580,896
+323,396
+126% +$3.22M
GFF icon
141
Griffon
GFF
$4.75B
$5.81M 0.16%
162,200
-162,200
-50% -$5.41M
GFF icon
142
PUT
Griffon
GFF
$4.75B
$5.81M 0.16%
162,200
-162,200
-50% -$5.41M
K
143
PUT
DELISTED
Kellanova
K
$5.75M 0.16%
+85,946
New +$5.83M
SDST
144
Stardust Power Inc
SDST
$7.13M
$5.69M 0.16%
56,303
+48,326
+606% +$4.85M
SLVR
145
DELISTED
SilverSPAC Inc. Class A Ordinary Share
SLVR
$5.68M 0.16%
566,951
+123,325
+28% +$1.22M
DMYS
146
DELISTED
dMY Technology Group, Inc. VI
DMYS
$5.65M 0.16%
561,839
+528,436
+1,582% +$5.26M
FTPA
147
DELISTED
FTAC Parnassus Acquisition Corp. Class A Common Stock
FTPA
$5.63M 0.15%
560,844
HCMA
148
DELISTED
HCM Acquisition Corp Class A Ordinary Shares
HCMA
$5.62M 0.15%
+547,368
New +$5.58M
SPWR icon
149
SunPower Inc
SPWR
$46.4M
$5.61M 0.15%
+554,951
New +$5.55M
IRAA
150
DELISTED
Iris Acquisition Corp Class A Common Stock
IRAA
$5.59M 0.15%
554,911
+333,548
+151% +$3.33M

Similar funds

Westchester Capital Management (New York)'s Q4 2022 Portfolio in Review

As of Q4 2022, Westchester Capital Management (New York) held 629 positions worth $3.64B, up 2.4% from $3.55B the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Westchester Capital Management (New York)'s Q4 2022 filing shows 150 new, 117 increased, 17 reduced and 182 closed positions. Its largest new stake was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,253,044 shares worth $143M. The largest sale was Biohaven Pharmaceutical Holding Company Ltd., an estimated $143M.

By sector, the portfolio is most concentrated in Financials at 41% of assets, up from 32% a quarter earlier, followed by Technology and Healthcare.

  • Westchester Capital Management (New York)'s largest Q4 2022 buy was Horizon Therapeutics Public Limited Company Ordinary Shares: 1,253,044 shares worth $143M.
  • Westchester Capital Management (New York) added most to Signify Health, Inc. in Q4 2022, an estimated $49.6M increase.
  • Westchester Capital Management (New York)'s biggest Q4 2022 reduction was Silicon Motion, cutting an estimated $61.4M.
  • Westchester Capital Management (New York) fully exited Biohaven Pharmaceutical Holding Company Ltd. in Q4 2022, selling an estimated $143M.
  • Westchester Capital Management (New York)'s ten largest holdings make up 32% of its $3.64B portfolio in Q4 2022.
  • Westchester Capital Management (New York) opened 150 new positions and closed 182 in Q4 2022.
  • Westchester Capital Management (New York)'s portfolio value rose 2.4% quarter-over-quarter to $3.64B.

Based on Westchester Capital Management (New York)'s 13F filing for Q4 2022, filed 14 Feb 2023.